Fennec Pharma Competitors and Similar CompaniesClear all
Fennec Pharma's competitors and similar companies include Urogen Pharma and LadRx.
 Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. | ||
Founding Date | Founding Date 1996 | Founding Date 2004 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Los Angeles, US HQ |
Employees | Employees 433% increase | Employees 194362% increase | Employees 385% decrease |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 515.9 m | Valuation ($) 901.1 k |
Financial | |||
Revenue (est.) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) | Net income ($1.6m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View companyLadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View company